CHRRF(CHRRF)
CHRRF
Q4 2026 EPS Estimate
$0.41
Nov 9, 2026
Revenue Estimate
$242M
FY2026E EPS$2.57
FY2027E EPS$2.50
No analyst ratings available
Price Target Expectations
Bear
$32.00
+50.6%
Consensus
$32.00
+50.6%
Bull
$32.00
+50.6%
12-Month Target Range0 analysts
$32.00$32.00$32.00
Current $21.25Consensus
Current Price
$21.25
Upside to Consensus
$10.75
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+0.17%
EPS-2.68%
FY2028
Rev-1.38%
EPS+3.11%
FY2029
Rev+2.05%
EPS-26.59%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $1.37B | $1.37B | $1.36B | $1.38B |
| Low | $1.33B | $1.22B | $1.25B | $1.28B |
| High | $1.42B | $1.48B | $1.43B | $1.46B |
| EBITDA Avg | $277M | $277M | $273M | $279M |
| Low | $268M | $245M | $253M | $258M |
| High | $286M | $299M | $289M | $295M |
| EBIT Avg | $113M | $113M | $111M | $113M |
| Low | $109M | $100M | $103M | $105M |
| High | $116M | $122M | $118M | $120M |
| Net Income Avg | $67M | $65M | $67M | $50M |
| Low | $61M | $59M | $61M | $45M |
| High | $72M | $70M | $72M | $53M |
| EPS Avg | $2.57 | $2.50 | $2.58 | $1.89 |
| Low | $2.32 | $2.26 | $2.33 | $1.71 |
| High | $2.76 | $2.68 | $2.77 | $2.03 |
| Analysts (Rev / EPS) | 7 / 1 | 7 / 1 | 3 / 1 | 3 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $344M | $340M | $348M | $352M | $343M | $340M | $371M | $353M |
| Low | $321M | $337M | $335M | $338M | $330M | $327M | $356M | $339M |
| High | $354M | $345M | $356M | $359M | $351M | $347M | $379M | $360M |
| EBITDA Avg | $69M | $69M | $70M | $71M | $69M | $69M | $75M | $71M |
| Low | $65M | $68M | $68M | $68M | $67M | $66M | $72M | $68M |
| High | $71M | $70M | $72M | $72M | $71M | $70M | $76M | $73M |
| EBIT Avg | $28M | $28M | $29M | $29M | $28M | $28M | $30M | $29M |
| Low | $26M | $28M | $27M | $28M | $27M | $27M | $29M | $28M |
| High | $29M | $28M | $29M | $29M | $29M | $28M | $31M | $30M |
| Net Income Avg | $14M | $14M | $14M | $15M | $14M | $14M | $17M | $16M |
| Low | $13M | $13M | $14M | $14M | $13M | $14M | $16M | $15M |
| High | $14M | $14M | $15M | $15M | $15M | $15M | $17M | $17M |
| EPS Avg | $0.58 | $0.59 | $0.61 | $0.64 | $0.61 | $0.62 | $0.71 | $0.69 |
| Low | $0.55 | $0.56 | $0.58 | $0.60 | $0.58 | $0.59 | $0.67 | $0.66 |
| High | $0.60 | $0.61 | $0.63 | $0.65 | $0.62 | $0.64 | $0.73 | $0.71 |
| Analysts (Rev / EPS) | 6 / 1 | 5 / 1 | 4 / 1 | 4 / 1 | 4 / 1 | 4 / 1 | 3 / 1 | 3 / 1 |